In line, in vitro studies suggested that hepatic steatosis sensitizes hepatocytes to TRAIL-mediated apoptosis [33], and that hepatic steatosis may also activate DR5 independently of TRAIL [34]. The gene discussed is TNFRSF10B; the disease is Hepatic steatosis.